510(k) DEN230008
DEN230008 is an FDA 510(k) premarket notification submitted by Dermasensor, Inc. for the device "DermaSensor". The FDA issued a decision of De Novo Granted on January 12, 2024. The device falls under product code QZS (Software-Aided Adjunctive Diagnostic Device For Use By Physicians On Lesions Suspicious For Skin Cancer), a Class II device regulated under 21 CFR 878.1830.
Clearance Details
- Decision
- DENG (De Novo Granted)
- Decision Date
- January 12, 2024
- Date Received
- February 2, 2023
- Clearance Type
- Direct
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Software-Aided Adjunctive Diagnostic Device For Use By Physicians On Lesions Suspicious For Skin Cancer
- Device Class
- Class II
- Regulation Number
- 878.1830
- Review Panel
- SU
- Submission Type
A software-aided adjunctive diagnostic device for use by physicians on lesions suspicious for skin cancer is a prescription device that uses a software algorithm to analyze optical or other physical properties of a skin lesion and returns a classification of the skin lesion. The device is intended for use by a physician not trained in the clinical diagnosis and management of skin cancer as an adjunctive second-read device following identification of a suspicious skin lesion. It is not for use as a standalone diagnostic and is not for use to confirm a clinical diagnosis.